INTRODUCTION
It is now well established that hydrolysis of both phosphoinositides and phosphatidylcholine (PtdCho) may account for accumulation of diacylglycerol (DG) during cell stimulation with Ca2l-mobilizing agonists [1] [2] [3] [4] . Cleavage of PtdIns(4,5)P2 by receptor-mediated activation of phospholipase C (PLC) has been invariably regarded as a major source of DG during cell stimulation [1] . PtdCho may provide an additional source of DG through two distinct pathways: first, through hydrolysis by PtdCho-specific PLC; and secondly, via hydrolysis by PtdChospecific phospholipase D (PLD) to choline and phosphatidic acid (PtdOH), followed by cleavage of the latter metabolite to phosphate and DG by PtdOH phosphohydrolase [2] [3] [4] .
Stimulation of phosphoinositide hydrolysis elicited by muscarinic agonists is a well-established phenomenon in a number of human neuroblastoma cell lines [5] [6] [7] [8] ; fewer studies have, conversely, dealt with muscarinic-receptor-mediated PtdCho breakdown. In particular, the relative contribution made by phosphoinositide and PtdCho hydrolysis to DG accumulation, and the metabolic routes through which PtdCho provides DG, remain largely to be investigated. In a recent study, Lee and coworkers analysed DG and PtdOH molecular species produced upon muscarinic stimulation of SK-N-SH human neuroblastoma [9] . These authors demonstrated that shortly after stimulation DG, mainly originates from phosphoinositides, whereas at later times PtdCho is a major source of this lipid through PLC release of [3H]PCho into the medium. PtdCho-specific phospholipase D (PLD) activation was documented by the accumulation of [3H] phosphatidylethanol in cells prelabelled with [3H]myristic acid and stimulated in the presence of 1 (v/v) ethanol; this metabolic pathway, however, proved to be a minor one leading to generation of phosphatidic acid (PtdOH) during cell stimulation, whereas DG production by the sequential action of PtdCho-specific PLD and PtdOH phosphohydrolase was not observed. Studies on cells which were double-labelled with [3H]myristic acid and [14C]arachidonic acid indicated that within 15 s of stimulation DG is uniquely derived from PtdIns(4,5)PJ, whereas PtdCho is the major source at later times. Evidence is provided that rapid and selective conversion ofphosphoinositidederived DG into PtdOH may play an important role in determining the temporal accumulation profile of DG from the above-mentioned sources.
hydrolysis; furthermore it was reported that SK-N-SH cells lack PtdCho-specific PLD activity [9] . PtdCho-specific PLD activation following muscarinic stimulation has, conversely, been demonstrated in LAN-2 cells [8] ; however, the issue of whether PtdOH originating from PtdCho hydrolysis undergoes dephosphorylation by PtdOH phosphohydrolase, thus providing a source of DG, has not been investigated. In this paper we report a study aimed at investigating the sources of DG as well as the metabolic routes by which DG is produced during muscarinic stimulation of the human neuroblastoma cell line SK-N-BE (2 [12] . Two-dimensional separation of phospholipids was carried out on high-performance t.l.c. plates as described [16] . Neutral lipids and free fatty acids were separated on high-performance t. (4) In the labelling conditions employed the 14C/3H isotopic ratio in Ptdlns was 20-fold higher than that observed in PtdCho (Table 2) ; the isotopic ratios are expected to be maintained in the metabolites of the two phospholipids, provided that no process of deacylation-reacylation occurs. Figure 5 (upper panel) shows that at the earliest time-points tested (i.e. 10 that the 14C/3H ratio observed in late accumulation of DG, as compared with that observed in phosphatidylethanolamine (PtdEtn), suggests that during this period this major phospholipid class does not provide a source of DG. Changes in DG labelling were accompanied by radioactivity accumulation in PtdOH ( Figure 5, lower panel) , the high 14C/3H ratio observed throughout the stimulation time course being strongly suggestive that PtdOH is mainly produced through phosphorylation of phosphoinositide-derived DG. To test this hypothesis a set of studies were performed with the compound R59022. R59022 is rega!ded as a specific inhibitor of DG kinase [20] ; however, it has also been shown to inhibit agonist binding at the level of muscarinic receptors by a competitive mechanism [21] . Table 3 shows the effect of 10 [9, 23, 24] and the possibility that it may be related to DG kinase specificity for AA-containing DG [25] remains to be investigated. Further efforts, of course, are required to elucidate the mechanisms leading to PtdCho-specific PLC activation and the role of PtdCho-derived DG.
